About Mona Khalid

VP, Portfolio Strategy & Scientific Affairs
Mona Khalid is Endpoint Health’s Vice President of Outcomes Research and Development, based in London, UK. Prior to joining Endpoint Health, Mona was Vice President, Real World Evidence, Outcomes Research & Epidemiology at Galapagos, a commercial stage biotechnology company. Prior to this, she was Global Head of Evidence and Value Generation (GI) at Takeda Pharmaceuticals. She brings broad experience from across the healthcare ecosystem to Endpoint Health and was previously Vice President, Outcomes Research and Development at the International Consortium of Health Outcomes Measurement (ICHOM).